Calamos Advisors’s Seagen Inc. Common Stock SGEN Stock Holding History

Calamos Advisors’s Portfolio SGEN Stock Details SGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-119,000	Closed	-$25.2M	–	999
2023 Q3	$25.2M	Sell	119,000 -44,748	-27%	-$8.94M	0.13%	200
2023 Q2	$31.5M	Buy	163,748 +87,940	+116%	+$17.5M	0.16%	172
2023 Q1	$15.3M	Buy	+75,808	New	+$12.2M	0.08%	326
2020 Q3	–	Sell	-4,072	Closed	-$692K	–	752
2020 Q2	$692K	Buy	+4,072	New	+$607K	﹤0.01%	665

Other funds holding SGEN

SCM

Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

FBC

Fairfield, Bush & Co Darien, Connecticut $180M AUM 39.51% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

SAG

Spotlight Asset Group Oakbrook Terrace, Illinois $143M AUM 20.66% 1-Year Est. Return

Calamos Advisors's SGEN Position: Q4 2023 in Review

Calamos Advisors sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 119,000 shares — an estimated $25.2M sold.

Calamos Advisors first reported a position in SGEN in Q2 2020 and held it in 4 quarters. The position peaked at $31.5M in Q2 2023. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.

Calamos Advisors reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Calamos Advisors sold 119,000 Seagen Inc. Common Stock shares in Q4 2023, an estimated $25.2M.
Calamos Advisors first reported a position in Seagen Inc. Common Stock in Q2 2020 and held it in 4 quarters.
Calamos Advisors's Seagen Inc. Common Stock position peaked at $31.5M in Q2 2023.
6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.

Based on Calamos Advisors's 13F filing for Q4 2023, filed 31 Jan 2024.